Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese

Yuri Moriyama, Tomonori Okamura, Kouji Kajinami, Hiroyasu Iso, Akihiro Inazu, Masaaki Kawashiri, Mihoko Mizuno, Yoshiko Takeda, Yasuki Sakamoto, Humio Kimura, Hideyoshi Suzuki, Hiroshi Mabuchi

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

High plasma homocysteine, a risk factor for atherosclerosis, is frequently caused by a common mutation in the gene for the enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR), C677T (alanine to valine substitution) or low intake of B vitamins that affect the remethylation or transsulfuration pathways in homocysteine metabolism. However, the interaction of the C677T mutation and B vitamins other than folate has not been well elucidated. We conducted a cross-sectional survey of 324 men and 641 women who participated in a 1996 health examination under a hypothesis that high nutritional status of folate, vitamin B12 and vitamin B6 expressed as high serum levels, may compensate for the hyperhomocysteinemia associated with homozygosity for the C677T mutation, but not for having the mutation per se. Age-adjusted plasma homocysteine levels were higher for both men and women with the homozygous genotype for the mutation than those who were heterozygous or had no mutation. Elevated homocysteine levels in homozygous genotype was attenuated among persons with higher serum levels of vitamin B12 and folate, but not vitamin B6, and among persons with the combination of lower folate and higher vitamin B12 and of higher folate and higher vitamin B12, split by the median. These findings suggest that elevated homocysteine levels among Japanese with the homozygous genotype for the MTHFR gene mutation can be modified efficiently by dietary supplement of vitamin B12 as well as folate.

Original languageEnglish
Pages (from-to)321-328
Number of pages8
JournalAtherosclerosis
Volume164
Issue number2
DOIs
Publication statusPublished - 2002 Oct
Externally publishedYes

Fingerprint

Methylenetetrahydrofolate Reductase (NADPH2)
Vitamin B Complex
Homocysteine
Folic Acid
Vitamin B 12
Mutation
Serum
Genes
Vitamin B 6
Genotype
Hyperhomocysteinemia
Valine
Dietary Supplements
Nutritional Status
Alanine
Atherosclerosis
Cross-Sectional Studies
Health
Enzymes

Keywords

  • Folate
  • Homocysteine
  • Japanese
  • Polymorphism
  • Pyridoxal 5′-phosphate
  • Vitamin B12

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. / Moriyama, Yuri; Okamura, Tomonori; Kajinami, Kouji; Iso, Hiroyasu; Inazu, Akihiro; Kawashiri, Masaaki; Mizuno, Mihoko; Takeda, Yoshiko; Sakamoto, Yasuki; Kimura, Humio; Suzuki, Hideyoshi; Mabuchi, Hiroshi.

In: Atherosclerosis, Vol. 164, No. 2, 10.2002, p. 321-328.

Research output: Contribution to journalArticle

Moriyama, Y, Okamura, T, Kajinami, K, Iso, H, Inazu, A, Kawashiri, M, Mizuno, M, Takeda, Y, Sakamoto, Y, Kimura, H, Suzuki, H & Mabuchi, H 2002, 'Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese', Atherosclerosis, vol. 164, no. 2, pp. 321-328. https://doi.org/10.1016/S0021-9150(02)00105-3
Moriyama, Yuri ; Okamura, Tomonori ; Kajinami, Kouji ; Iso, Hiroyasu ; Inazu, Akihiro ; Kawashiri, Masaaki ; Mizuno, Mihoko ; Takeda, Yoshiko ; Sakamoto, Yasuki ; Kimura, Humio ; Suzuki, Hideyoshi ; Mabuchi, Hiroshi. / Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. In: Atherosclerosis. 2002 ; Vol. 164, No. 2. pp. 321-328.
@article{518030b8527f4734bf79cbb7ad040a5d,
title = "Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese",
abstract = "High plasma homocysteine, a risk factor for atherosclerosis, is frequently caused by a common mutation in the gene for the enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR), C677T (alanine to valine substitution) or low intake of B vitamins that affect the remethylation or transsulfuration pathways in homocysteine metabolism. However, the interaction of the C677T mutation and B vitamins other than folate has not been well elucidated. We conducted a cross-sectional survey of 324 men and 641 women who participated in a 1996 health examination under a hypothesis that high nutritional status of folate, vitamin B12 and vitamin B6 expressed as high serum levels, may compensate for the hyperhomocysteinemia associated with homozygosity for the C677T mutation, but not for having the mutation per se. Age-adjusted plasma homocysteine levels were higher for both men and women with the homozygous genotype for the mutation than those who were heterozygous or had no mutation. Elevated homocysteine levels in homozygous genotype was attenuated among persons with higher serum levels of vitamin B12 and folate, but not vitamin B6, and among persons with the combination of lower folate and higher vitamin B12 and of higher folate and higher vitamin B12, split by the median. These findings suggest that elevated homocysteine levels among Japanese with the homozygous genotype for the MTHFR gene mutation can be modified efficiently by dietary supplement of vitamin B12 as well as folate.",
keywords = "Folate, Homocysteine, Japanese, Polymorphism, Pyridoxal 5′-phosphate, Vitamin B12",
author = "Yuri Moriyama and Tomonori Okamura and Kouji Kajinami and Hiroyasu Iso and Akihiro Inazu and Masaaki Kawashiri and Mihoko Mizuno and Yoshiko Takeda and Yasuki Sakamoto and Humio Kimura and Hideyoshi Suzuki and Hiroshi Mabuchi",
year = "2002",
month = "10",
doi = "10.1016/S0021-9150(02)00105-3",
language = "English",
volume = "164",
pages = "321--328",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese

AU - Moriyama, Yuri

AU - Okamura, Tomonori

AU - Kajinami, Kouji

AU - Iso, Hiroyasu

AU - Inazu, Akihiro

AU - Kawashiri, Masaaki

AU - Mizuno, Mihoko

AU - Takeda, Yoshiko

AU - Sakamoto, Yasuki

AU - Kimura, Humio

AU - Suzuki, Hideyoshi

AU - Mabuchi, Hiroshi

PY - 2002/10

Y1 - 2002/10

N2 - High plasma homocysteine, a risk factor for atherosclerosis, is frequently caused by a common mutation in the gene for the enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR), C677T (alanine to valine substitution) or low intake of B vitamins that affect the remethylation or transsulfuration pathways in homocysteine metabolism. However, the interaction of the C677T mutation and B vitamins other than folate has not been well elucidated. We conducted a cross-sectional survey of 324 men and 641 women who participated in a 1996 health examination under a hypothesis that high nutritional status of folate, vitamin B12 and vitamin B6 expressed as high serum levels, may compensate for the hyperhomocysteinemia associated with homozygosity for the C677T mutation, but not for having the mutation per se. Age-adjusted plasma homocysteine levels were higher for both men and women with the homozygous genotype for the mutation than those who were heterozygous or had no mutation. Elevated homocysteine levels in homozygous genotype was attenuated among persons with higher serum levels of vitamin B12 and folate, but not vitamin B6, and among persons with the combination of lower folate and higher vitamin B12 and of higher folate and higher vitamin B12, split by the median. These findings suggest that elevated homocysteine levels among Japanese with the homozygous genotype for the MTHFR gene mutation can be modified efficiently by dietary supplement of vitamin B12 as well as folate.

AB - High plasma homocysteine, a risk factor for atherosclerosis, is frequently caused by a common mutation in the gene for the enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR), C677T (alanine to valine substitution) or low intake of B vitamins that affect the remethylation or transsulfuration pathways in homocysteine metabolism. However, the interaction of the C677T mutation and B vitamins other than folate has not been well elucidated. We conducted a cross-sectional survey of 324 men and 641 women who participated in a 1996 health examination under a hypothesis that high nutritional status of folate, vitamin B12 and vitamin B6 expressed as high serum levels, may compensate for the hyperhomocysteinemia associated with homozygosity for the C677T mutation, but not for having the mutation per se. Age-adjusted plasma homocysteine levels were higher for both men and women with the homozygous genotype for the mutation than those who were heterozygous or had no mutation. Elevated homocysteine levels in homozygous genotype was attenuated among persons with higher serum levels of vitamin B12 and folate, but not vitamin B6, and among persons with the combination of lower folate and higher vitamin B12 and of higher folate and higher vitamin B12, split by the median. These findings suggest that elevated homocysteine levels among Japanese with the homozygous genotype for the MTHFR gene mutation can be modified efficiently by dietary supplement of vitamin B12 as well as folate.

KW - Folate

KW - Homocysteine

KW - Japanese

KW - Polymorphism

KW - Pyridoxal 5′-phosphate

KW - Vitamin B12

UR - http://www.scopus.com/inward/record.url?scp=0036800979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036800979&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(02)00105-3

DO - 10.1016/S0021-9150(02)00105-3

M3 - Article

C2 - 12204804

AN - SCOPUS:0036800979

VL - 164

SP - 321

EP - 328

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -